Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological conditions, today announced…
Rugiet Named Official Men’s Prescription Partner of the Detroit Pistons Rugiet, a men’s healthcare platform, today announced its designation as the official men’s Rx partner for the Detroit Pistons. The partnership marks the franchise’s first-ever collaboration in men’s health and…
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC Bruker Corporation today announced the launch of iNTApharma, a label‑free characterization platform that provides single‑particle sensitivity for the quantitative analysis of nanoscale bioparticles in native aqueous…
Eurofins Viracor BioPharma Expands Bioanalytical Capabilities Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition…
restor3d Announces Full Commercial Launch of Ossera™ AFX Ankle Fusion Cage System, Immediately Available in Both Standard and Made-to-Order Options restor3d, a leader in 3D-printed, personalized orthopedic solutions, today announced the full commercial launch of the Ossera™ AFX Ankle Fusion Cage…
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence Evinova today announced that Bristol Myers Squibb has signed an agreement to optimize clinical trials with Evinova’s AI-native clinical development platform. Under the terms of…
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium Johnson & Johnson today announced 12-month pilot-phase data from the OMNY-AF study, evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation…
RUBAR Acquired by ETi Gıda for $173 Million, Ushering in Next Phase of Global Growth TRUBAR, the fast-growing protein bar brand known for its dessert-inspired flavors and clean ingredients, today announced the completion of its acquisition by ETi Gıda, a…
A Legacy of Brighter Smiles: Celebrating 24 Years of the Give Kids A Smile Program The American Dental Association Foundation (ADAF) is officially kicking off Give Kids A Smile® (GKAS) 2026 at UTHealth Houston School of Dentistry, marking 24 years of transforming children’s lives…
Applied Medical Prevails in Antitrust Jury Trial Against Medtronic Applied Medical announced today a significant legal victory that should help open the healthcare market to innovation and lower costs. A U.S. District Court jury unanimously found Medtronic, Inc. liable for…
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for…
Bayer’s Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus Placebo Bayer today presented the results from the global, pivotal Phase III OCEANIC-STROKE…